<DOC>
	<DOC>NCT02135679</DOC>
	<brief_summary>Patients with NSCLC who undergo radiation as part of a definitive course of treatment will be enrolled. Blood collections will be obtained before, during, and after radiotherapy. We will collect demographic and treatment data and explore &amp; describe the pattern of CTC detection in all patients</brief_summary>
	<brief_title>The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplastic Cells, Circulating</mesh_term>
	<criteria>Patients with biopsyproven NSCLC who are undergoing definitive radiotherapy as a part of their treatment regimen. Age 18 or older Signed informed consent Patients who are incapable of providing informed consent are excluded from participating in this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>